First-in-Human Trial of DS1025a in Participants With Advanced Solid Tumors
NCT07681882
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Metastatic Solid Tumor
Unresectable Solid Tumor
Interventions
DRUG:
DS1025a
Sponsor
Daiichi Sankyo